UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000023666
Receipt No. R000027260
Scientific Title Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study-
Date of disclosure of the study information 2016/08/18
Last modified on 2016/10/14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study-
Acronym Suppressive effect of combination of test food on the postprandial triglyceride level
Scientific Title Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study-
Scientific Title:Acronym Suppressive effect of combination of test food on the postprandial triglyceride level
Region
Japan

Condition
Condition None
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effect of test food on the postprandial blood triglyceride level of subjects.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Area under the curve for serum triglyceride level
Key secondary outcomes Fasting serum triglyceride level, serum triglyceride levels of 2, 3, 4, and 6 hours after high fate meal ingestion, Remnant-like particle cholesterol

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Intake of test food, and then ingestion of placebo after wash out period.
Interventions/Control_2 Intake of placebo, and then ingestion of test food after wash out period.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria 1) Males and females 20 to 64 years of age
2) Subjects whose fasting serum triglyceride levels are less than 200 mg/dL.
Key exclusion criteria 1) Subjects who routinely use medicine related to lipid metabolism.
2) Subjects who routinely use medicine, supplements, FOSHU, and/or health food which affect to result of the study.
3) Subjects who have allergy to test food and/or high fat meal and have
extreme lactose intolerance or diarrhea.
4) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating.
5) Heavy user of alcohol or excessive smokers
6) Subjects who have under treatment of chronic disease and routinely uses a medicine.
Target sample size 60

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Jyouji Kurokawa
Organization Medical Corporation Shoureikan Sinsapporo seiryou Hospital
Division name General Clinical Department
Zip code
Address 2-1-30, Atsubetsuhigashi4jo, Atsubetsu-ku, Sapporo, Hokkaido, Japan
TEL 011-898-2151
Email j.kurokawa@shoureikan.jp

Public contact
Name of contact person
1st name
Middle name
Last name Masaya Tsubokawa
Organization FANCL Corporation
Division name Research Institute
Zip code
Address 12-13 Kamishinano, Totsuka-ku, Yokohama, Kanagawa, Japan
TEL 045-820-3569
Homepage URL
Email tsubokawa_masaya@fancl.co.jp

Sponsor
Institute FANCL Corporation
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Jpan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 医療法人社団翔嶺館新札幌聖陵ホスピタル

Other administrative information
Date of disclosure of the study information
2016 Year 08 Month 18 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 07 Month 21 Day
Date of IRB
Anticipated trial start date
2016 Year 08 Month 19 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2016 Year 08 Month 18 Day
Last modified on
2016 Year 10 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027260

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.